AlphaStocks
4.9
Weak

OMNICELL, INC. (OMCL)

Health Care / Health Care Technology

S&P SmallCap 600

$33.96

Below average on several measures. Research carefully.

Weak

Score based on 5 of 5 models — high confidence

#602out of 1127 in Health Care

Is OMNICELL, INC. a Good Investment in 2026?

OMNICELL, INC. (OMCL) scores 4.9 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates OMNICELL, INC. as Attractive (6/9). However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 88%). OMNICELL, INC. currently trades above its estimated fair value of $20, suggesting limited upside at current prices. OMNICELL, INC. ranks #602 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE0.2Market Cap2B

Estimated Fair Value

$19.6773% above

Trading above estimated fair value. P/e of 767x implies high growth expectations. eps growth of -84% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Neutral

High PEG — growth premium · Fast Grower

Greenblatt

Caution

Bottom half (rank 88%)

Frequently Asked Questions

Is OMNICELL, INC. (OMCL) a good investment?
Based on AlphaStocks' composite analysis, OMNICELL, INC. (OMCL) scores 4.9 out of 10, earning a Weak rating. This score is below average, suggesting caution. Trading above estimated fair value. P/e of 767x implies high growth expectations. eps growth of -84% may not justify the premium.
What is OMNICELL, INC.'s Piotroski F-Score?
OMNICELL, INC.'s Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is OMCL overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $20, OMCL appears overvalued. The stock currently trades 73% above its estimated fair value. Trading above estimated fair value. P/e of 767x implies high growth expectations. eps growth of -84% may not justify the premium.
How does OMCL compare to other Health Care stocks?
OMNICELL, INC. ranks #602 out of 1127 stocks in the Health Care sector, placing it in the top 53% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about OMCL?
AlphaStocks evaluates OMCL using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 4.9/10.

Similar Stocks

PARRFTIAZN

Compare OMCL with

OMCL vs PARROMCL vs FTIOMCL vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer